Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056550
Status:
COMPLETED
Last Update Posted:
2012-10-16
First Post:
2003-03-17
Brief Title:
Assess Incidence of Deep Vein ThrombosisDVTFollowing Administration of Recombinant Human Antithrombin rhAT to Hereditary AntithrombinAT Deficient Patients in High Risk Situations
Sponsor:
rEVO Biologics
Organization:
rEVO Biologics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2004-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-02
Completion Date Type:
ACTUAL
First Submit Date:
2003-03-17
First Submit QC Date:
March 17 2003
Study First Post Date:
2003-03-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-10-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-17
Last Update Post Date:
2012-10-16
Last Update Post Date Type:
ESTIMATED